C.J.H. van de Velde

5.6k total citations · 2 hit papers
52 papers, 4.1k citations indexed

About

C.J.H. van de Velde is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, C.J.H. van de Velde has authored 52 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Surgery and 14 papers in Cancer Research. Recurrent topics in C.J.H. van de Velde's work include Colorectal Cancer Surgical Treatments (14 papers), Breast Cancer Treatment Studies (9 papers) and Colorectal Cancer Screening and Detection (8 papers). C.J.H. van de Velde is often cited by papers focused on Colorectal Cancer Surgical Treatments (14 papers), Breast Cancer Treatment Studies (9 papers) and Colorectal Cancer Screening and Detection (8 papers). C.J.H. van de Velde collaborates with scholars based in Netherlands, Belgium and Japan. C.J.H. van de Velde's co-authors include Corrie A.M. Marijnen, M.F. von Meyenfeldt, Jos A. van der Hage, Ilfet Songun, Elma Meershoek‐Klein Kranenbarg, C. W. Taat, John Th. M. Plukker, H. Obertop, Johannes J. Bonenkamp and Mitsuru Sasako and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

C.J.H. van de Velde

49 papers receiving 4.0k citations

Hit Papers

Extended Lymph-Node Dissection for Gastric Cancer 1999 2026 2008 2017 1999 2004 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.J.H. van de Velde Netherlands 24 2.1k 2.0k 1.7k 1.0k 576 52 4.1k
Tae Sung Sohn South Korea 34 3.2k 1.6× 1.7k 0.8× 1.1k 0.6× 1.5k 1.5× 272 0.5× 127 4.3k
Simon Weeden United Kingdom 13 5.5k 2.7× 3.2k 1.6× 1.5k 0.9× 2.2k 2.1× 282 0.5× 19 6.4k
Cornelis JH van de Velde Netherlands 20 1.7k 0.8× 2.1k 1.0× 2.5k 1.5× 710 0.7× 381 0.7× 25 4.3k
Hyo Song Kim South Korea 34 2.0k 1.0× 809 0.4× 1.8k 1.1× 339 0.3× 536 0.9× 182 3.7k
Emre F. Yekebas Germany 35 1.6k 0.8× 2.1k 1.0× 2.6k 1.5× 256 0.2× 445 0.8× 115 4.3k
Jae Moon Bae South Korea 31 2.7k 1.3× 1.4k 0.7× 987 0.6× 1.3k 1.3× 360 0.6× 132 3.9k
Peter Thuss‐Patience Germany 33 2.9k 1.4× 1.7k 0.9× 2.2k 1.3× 927 0.9× 243 0.4× 178 4.3k
Daniel Vallböhmer Germany 36 1.9k 0.9× 2.0k 1.0× 1.4k 0.8× 321 0.3× 493 0.9× 138 3.7k
Scott A. Hundahl United States 24 4.3k 2.1× 3.3k 1.7× 1.7k 1.0× 1.9k 1.8× 318 0.6× 42 7.4k
Klaus Gellert Germany 23 1.6k 0.8× 2.1k 1.1× 3.4k 2.0× 413 0.4× 1.1k 1.9× 51 4.7k

Countries citing papers authored by C.J.H. van de Velde

Since Specialization
Citations

This map shows the geographic impact of C.J.H. van de Velde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J.H. van de Velde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J.H. van de Velde more than expected).

Fields of papers citing papers by C.J.H. van de Velde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J.H. van de Velde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J.H. van de Velde. The network helps show where C.J.H. van de Velde may publish in the future.

Co-authorship network of co-authors of C.J.H. van de Velde

This figure shows the co-authorship network connecting the top 25 collaborators of C.J.H. van de Velde. A scholar is included among the top collaborators of C.J.H. van de Velde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J.H. van de Velde. C.J.H. van de Velde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulder, Babs G. Sibinga, Henricus J.M. Handgraaf, Daniëlle J. Vugts, et al.. (2018). PET/CT and near-infrared fluorescence imaging of tumors using a cRGD-based multimodal imaging agent. HPB. 20. S774–S774. 1 indexed citations
2.
Hartgrink, H.H., Johan L. Dikken, Wobbe O. de Steur, et al.. (2018). Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial. European Journal of Surgical Oncology. 44(5). 613–619. 38 indexed citations
3.
Geus, Susanna W.L. de, J. Sven D. Mieog, Rutger‐Jan Swijnenburg, et al.. (2016). Predictive Biomarkers for Short-Term Survival After Curative Intent Pancreatic Cancer Surgery : Identifying the Biologically Ill-Fated. Pancreas. 45(10). 1502–1502. 3 indexed citations
4.
Smit, Noeska, Nicholas P. West, Philip Quirke, et al.. (2014). 62. The virtual surgical pelvis: A highly-detailed 3D pelvic model for anatomical education and surgical simulation. European Journal of Surgical Oncology. 40(11). S32–S32. 1 indexed citations
5.
Bastiaannet, Esther, Ronald van Eijk, Ronald L. P. van Vlierberghe, et al.. (2013). COX-2 expression influences the prognostic effect of aspirin use after diagnosis in colon cancer patients. European Journal of Cancer. 49.
6.
Breugom, A.J., C.B.M. van den Broek, W. van Gijn, et al.. (2013). The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemoradiation followed by TME-surgery: The PROCTOR/SCRIPT study. European Journal of Cancer. 49. 10 indexed citations
7.
Hezewijk, Marjan van, et al.. (2011). Patients’ needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner. European Journal of Surgical Oncology. 37(9). 765–773. 30 indexed citations
8.
Nes, Johanna G. H. van, Hein Putter, Marjan van Hezewijk, et al.. (2010). Tailored follow-up for early breast cancer patients: A prognostic index that predicts locoregional recurrence. European Journal of Surgical Oncology. 36(7). 617–624. 12 indexed citations
9.
Lange, M., Corrie A.M. Marijnen, Cornelis P. Maas, et al.. (2009). Risk factors for sexual dysfunction after rectal cancer treatment. European Journal of Cancer. 45(9). 1578–1588. 173 indexed citations
10.
Iersel, L.B.J. van, Hans Gelderblom, Alexander L. Vahrmeijer, et al.. (2008). Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Annals of Oncology. 19(6). 1127–1134. 38 indexed citations
11.
Straver, Marieke E., Philip Meijnen, Geertjan van Tienhoven, et al.. (2008). Current status of the EORTC 10981–22023 AMAROS trial – After mapping of the axilla radiotherapy or surgery. European Journal of Cancer Supplements. 6(7). 147–147. 2 indexed citations
12.
Lange, M., H.J.T. Rutten, & C.J.H. van de Velde. (2008). One hundred years of curative surgery for rectal cancer: 1908–2008. European Journal of Surgical Oncology. 35(5). 456–463. 54 indexed citations
13.
Voogd, Adri C., Emiel J. Rutgers, Paula H.M. Elkhuizen, et al.. (2005). Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. European Journal of Cancer. 41(17). 2637–2644. 69 indexed citations
14.
Hoetelmans, Rob W.M., Alexander L. Vahrmeijer, Ronald L. P. van Vlierberghe, et al.. (2003). The role of various Bcl‐2 domains in the anti‐proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain. Cell Proliferation. 36(1). 35–44. 16 indexed citations
15.
Therasse, Patrick, et al.. (2001). The Importance of Quality Assurance in Surgical Oncology in the Treatment of Colorectal Cancer. Surgical Oncology Clinics of North America. 10(4). 885–914. 12 indexed citations
16.
Hoetelmans, Rob W.M., Henk-Jan van Slooten, R Keijzer, C.J.H. van de Velde, & Jan Hein van Dierendonck. (2001). Routine Formaldehyde Fixation Irreversibly Reduces Immunoreactivity of Bcl-2 in the Nuclear Compartment of Breast Cancer Cells, but not in the Cytoplasm. Applied immunohistochemistry & molecular morphology. 9(1). 74–80. 3 indexed citations
17.
Hoetelmans, Rob W.M., et al.. (2000). Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells. Cell Death and Differentiation. 7(4). 384–392. 89 indexed citations
18.
Nagtegaal, Irıs D., Elma Meershoek‐Klein Kranenbarg, Jos Hermans, C.J.H. van de Velde, & J. Han van Krieken. (2000). Pathology Data in the Central Databases of Multicenter Randomized Trials Need to Be Based on Pathology Reports and Controlled by Trained Quality Managers. Journal of Clinical Oncology. 18(8). 1771–1779. 51 indexed citations
19.
Bonenkamp, Johannes J., J. Hermans, Mitsuru Sasako, et al.. (1999). Extended Lymph-Node Dissection for Gastric Cancer. New England Journal of Medicine. 340(12). 908–914. 1178 indexed citations breakdown →
20.
Nakajima, Toshifusa, et al.. (1989). Changing patterns in gastric adenocarcinoma. British journal of surgery. 76(9). 914–916. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026